silver has been researched along with Prostatic Neoplasms in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.02) | 18.7374 |
| 1990's | 13 (22.81) | 18.2507 |
| 2000's | 8 (14.04) | 29.6817 |
| 2010's | 14 (24.56) | 24.3611 |
| 2020's | 18 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Gao, S; Gong, W; Lin, J; Lin, Y; Xie, S; Yu, Y; Zhao, X | 1 |
| Bright, R; Girija, AR; Kodama, T; Lebepe, TC; Maluleke, R; Ncapayi, V; Ninan, N; Oluwafemi, OS; Parani, S; Tsolekile, N; Vasilev, K | 1 |
| AbdEl-Hamid, OM; El-Magid, ADA; Younes, MA | 1 |
| Aljabali, AAA; Arshad, F; Birkett, M; Haggag, Y; Hassan, IU; Khan, R; Mishra, V; Mishra, Y; Naikoo, GA; Pedram, MZ; Pourfarzad, H; Serrano-Aroca, Á; Tambuwala, MM; Zedegan, MS | 1 |
| Cheng, W; Khan, A; Kong, D; Li, J; Sun, Y; Yi, Y; Zhang, J; Zhang, Z; Zhao, G | 1 |
| Kumar, A; Kumari, R; Saini, AK; Saini, RV | 1 |
| Chen, S; Chen, Y; Qi, S; Xu, Y; Yang, T; Zhang, Z | 1 |
| Asser, T; Bjerkvig, R; Kopanchuk, S; Kurm, K; Lingasamy, P; Rätsep, T; Salumäe, M; Sudakov, A; Teesalu, T; Tobi, A | 1 |
| Acharya, A; Mishra, A; Shyanti, RK; Singh, RP; Singh, SP | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Attygalle, A; Chi, J; Du, H; Kim, IY; Ma, Y; Zheng, Z | 1 |
| Cui, HP; Gao, HB; Han, LG; Li, ZY; Zhang, WH; Zhang, XF | 1 |
| Arkan, E; Behbood, L; Darvishi, E; Ehzari, H; Shahlaei, M | 1 |
| Cho, BH; Jung, HS; Lee, MY; Lim, K; Phyo, JB; Woo, A; Yu, HJ | 1 |
| An, J; Bock, S; Choi, Y; Hahm, E; Huynh, KH; Jeong, DH; Jun, BH; Kim, HM; Kim, J; Kim, JW; Lee, HY; Lee, S; Pham, XH; Rho, WY; Song, H | 1 |
| Arisha, AH; Edrees, N; El-Sayed, H; El-Sheikh, SMA; Eleiwa, NZ; Galal, AAA; Khamis, T; Metwally, MMM | 1 |
| El-Shemy, HA; Gavamukulya, Y; Kangogo, GK; Magoma, G; Maina, EN; Meroka, AM; Wamunyokoli, F | 1 |
| Cao, X; Li, L; Lu, W; Mao, Y; Song, Q; Sun, Y | 1 |
| Kang, JS; Park, JW | 1 |
| Balzerová, A; Bařinková, J; Beneš, P; Chaloupková, Z; Konvalinka, J; Medříková, Z; Ranc, V; Šácha, P; Zbořil, R | 1 |
| Abou-Hassan, A; Alvarez-Lorenzo, C; Botton, GA; Bugnet, M; Cabana, S; Curcio, A; Espinosa, A; Kolosnjaj-Tabi, J; Péchoux, C; Radtke, G; Silva, AKA; Wilhelm, C | 1 |
| Chen, Y; Jia, Z; Jiang, T; Liu, Y; Petti, L; Wang, F; Wang, X; Xiong, Q; Zhou, J; Zhou, L | 1 |
| Koo, KM; Trau, M; Wang, J; Wang, Y | 1 |
| Chen, X; Gao, Y; Hao, M; Jiang, J; Kong, C; Li, J; Wang, Y; Yang, B; Zhang, H; Zhao, X | 1 |
| Chang, N; Chen, R; Dong, J; Ge, Q; Liu, B; Luan, C; Ni, H; Zhao, X | 1 |
| Aziz Ibrahim, IA; Liu, X; M Nassir, A; Ramachandran, A; Samuel Ravi, SOA; Yao, J; Zhang, K | 1 |
| Braun, GB; de Mendoza, TH; French, RP; Kotamraju, VR; Lowy, AM; Ruoslahti, E; Sugahara, KN; Teesalu, T | 1 |
| Cao, D; Fu, Q; Huang, C; Lan, C; Li, X; Liang, J; Tang, Y; Wu, Z; Yao, C | 1 |
| Du, B; Li, X; Li, Y; Ma, H; Wei, Q; Wu, D; Yan, T; Zhang, Y | 1 |
| Dash, A; Kumar, Y; Muthe, KP; Saxena, SK; Sharma, SD; Venkatesh, M | 1 |
| Braun, GB; Reich, NO; Shi, Y; Stucky, G; Sun, X; Zhang, F; Zhang, Y; Zhao, D | 1 |
| Gregas, MK; Lauly, B; Scaffidi, JP; Vo-Dinh, T | 1 |
| Braun, GB; Moskovits, M; Pallaoro, A | 1 |
| Balakrishnan, SA; Majali, MA; Mathew, C | 1 |
| Hammond, RR; Leung, FY; Mirsattari, SM; Sharpe, MD; Young, GB | 1 |
| Berta, C; Borzillary, S; Detorie, N; Greenberg, M; Nobile, L; Sam, C; Shickell, D; Weiss, S; Welsh, JS | 1 |
| Kneipp, H; Kneipp, J; Kneipp, K; Rice, WL | 1 |
| Grogan, T; Hainfeld, JF; Hicks, DG; Pettay, J; Powell, R; Powell, W; Roche, P; Tubbs, R | 1 |
| Helpap, B; Riede, C | 1 |
| Bittinger, A; Melekos, MD; Rüschoff, J; von Keitz, A | 1 |
| Ahiskali, R; Akdaş, A; Alican, Y; Cevik, I; Ekicioğlu, G; Küllü, S | 1 |
| Akakura, K; Akimoto, S; Amakasu, M; Masai, M; Shimazaki, J | 1 |
| Chiusa, L; Di Primio, O; Formiconi, A; Galliano, D; Pich, A | 1 |
| Cochran, ST; Mesa, A; Norman, A; Solberg, TD | 1 |
| Abe, K; Akimoto, S; Masai, M; Shimazaki, J; Yatani, R | 1 |
| Adnet, JJ; Bonnet, N; Bourzat, C; Canellas, JC; Lechki, C; Ploton, D; Visseaux-Coletto, B | 1 |
| Broggini, P; Campo, B; Corrada, P; Derenzini, M; Lardennois, B; Marandola, P; Ploton, D; Roggia, A; Treré, D; Valentino, V | 1 |
| Hansen, AB; Ostergård, B | 1 |
| Cheville, JC; Clamon, GH; Robinson, RA | 1 |
| Elfving, P; Heim, S; Henrikson, H; Limon, J; Lundgren, R; Mamaev, N; Mamaeva, S; Mandahl, N; Mitelman, F | 1 |
| Korkut, E; Schally, AV; Szepeshazi, K | 1 |
| Deschênes, J; Weidner, N | 1 |
| Adnet, JJ; Himber, G; Jeannesson, P; Menager, M; Pigeon, F; Ploton, D | 1 |
| Abrahamsson, PA; Alumets, J; Falkmer, S; Grimelius, L; Wadström, LB | 1 |
| Abrahamsson, PA; Falkmer, S; Fält, K; Grimelius, L | 1 |
| Kazzaz, BA | 1 |
| Hirano, K; Hirota, K; Iguchi, K; Okumura, N; Sajiki, H; Usui, S | 1 |
2 review(s) available for silver and Prostatic Neoplasms
| Article | Year |
|---|---|
Advances in nanomaterial-based immunosensors for prostate cancer screening.
Topics: Biomarkers; Biosensing Techniques; Copper; Early Detection of Cancer; Electrochemical Techniques; Gold; Humans; Immunoassay; Male; Nanostructures; Prostate-Specific Antigen; Prostatic Neoplasms; Silver | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
3 trial(s) available for silver and Prostatic Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Evaluation of three different AgNOR counting methods in advanced carcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Histological Techniques; Humans; Male; Middle Aged; Neoplasm Staging; Nucleolus Organizer Region; Observer Variation; Prostatic Neoplasms; Reproducibility of Results; Silver; Staining and Labeling | 1995 |
Nucleolar organizer regions: preliminary results of the clinical use of a new marker for prostatic carcinoma (40 cases).
Topics: Adenocarcinoma; Biomarkers, Tumor; France; Humans; Italy; Male; Neoplasm Proteins; Nucleolus Organizer Region; Prognosis; Prostatic Neoplasms; Retrospective Studies; Silver | 1992 |
53 other study(ies) available for silver and Prostatic Neoplasms
| Article | Year |
|---|---|
Label-free surface enhanced Raman spectroscopy analysis of blood serum via coffee ring effect for accurate diagnosis of cancers.
Topics: Coffee; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Reproducibility of Results; Serum; Silver; Spectrum Analysis, Raman | 2022 |
Diagnosis of Prostate Cancer and Prostatitis Using near Infra-Red Fluorescent AgInSe/ZnS Quantum Dots.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Humans; Indium; Male; Mammary Neoplasms, Animal; Mice; Prostatic Neoplasms; Prostatitis; Quantum Dots; Selenium; Silver; Staphylococcus aureus; Sulfides; Water; Zinc Compounds | 2021 |
The Biochemical Effects of Silver Nanoparticles and Spirulina Extract on Experimentally Induced Prostatic Cancer in Rats.
Topics: Animals; Humans; Interleukin-6; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Silver; Spirulina; Testosterone | 2023 |
A novel peptide-templated AgNPs nanoprobe for theranostics of prostate cancer.
Topics: Biosensing Techniques; Electrochemical Techniques; Exosomes; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Peptides; Precision Medicine; Prostatic Neoplasms; Silver | 2023 |
Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction.
Topics: Apoptosis; Cell Line, Tumor; Green Chemistry Technology; Humans; Lung Neoplasms; Male; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Pinus; Prostatic Neoplasms; Reactive Oxygen Species; Silver; Spectrum Analysis | 2020 |
Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells.
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Cell Hypoxia; Cell Survival; Drug Delivery Systems; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysosomes; Male; Metal Nanoparticles; PC-3 Cells; Prostatic Neoplasms; Signal Transduction; Silver; TOR Serine-Threonine Kinases; Transfection | 2020 |
Tumor-penetrating peptide for systemic targeting of Tenascin-C.
Topics: Animals; Antineoplastic Agents; Cell-Penetrating Peptides; Female; Glioblastoma; Humans; Male; Metal Nanoparticles; Mice; Mice, Nude; Neuropilin-1; PC-3 Cells; Prostatic Neoplasms; Protein Binding; Silver; Tenascin; Tissue Distribution; Tumor Microenvironment | 2020 |
Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells.
Topics: Apoptosis; Carica; Cell Cycle Checkpoints; Humans; Male; Metal Nanoparticles; Plant Extracts; Prostate; Prostatic Neoplasms; Silver | 2021 |
Therapeutic prognosis of prostate cancer using surface-enhanced Raman scattering of patient urine and multivariate statistical analysis.
Topics: Discriminant Analysis; Humans; Male; Metal Nanoparticles; Principal Component Analysis; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman | 2021 |
Preparation of
Topics: Brachytherapy; Carbon; Humans; Iodine Radioisotopes; Male; Prostatic Neoplasms; Radiography; Silver; Tomography, X-Ray Computed | 2021 |
The electrochemical immunosensor for detection of prostatic specific antigen using quince seed mucilage-GNPs-SNPs as a green composite.
Topics: Biomarkers, Tumor; Biosensing Techniques; Calendula; Dielectric Spectroscopy; Gold; Green Chemistry Technology; Humans; Kallikreins; Male; Metal Nanoparticles; Nanocomposites; Plant Extracts; Plant Mucilage; Prostate-Specific Antigen; Prostatic Neoplasms; Rosaceae; Seeds; Silver | 2021 |
Label-Free SERS Analysis of Urine Using a 3D-Stacked AgNW-Glass Fiber Filter Sensor for the Diagnosis of Pancreatic Cancer and Prostate Cancer.
Topics: Glass; Humans; Male; Pancreatic Neoplasms; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman | 2021 |
Au-Ag assembled on silica nanoprobes for visual semiquantitative detection of prostate-specific antigen.
Topics: Biosensing Techniques; Colorimetry; Gold; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Silicon Dioxide; Silver | 2021 |
Could Cisplatin Loading on Biosynthesized Silver Nanoparticles Improve Its Therapeutic Efficacy on Human Prostate Cancer Cell Line and Reduce Its In Vivo Nephrotoxic Effects?
Topics: Animals; Antineoplastic Agents; Cell Line; Cisplatin; Humans; Male; Metal Nanoparticles; Plant Extracts; Prostatic Neoplasms; Rats; Rats, Wistar; Silver | 2022 |
Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis.
Topics: Adenocarcinoma; Annona; Antineoplastic Agents; Caspase 9; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Chemokine CXCL1; Female; Gene Expression Regulation, Neoplastic; Green Chemistry Technology; Humans; Male; Metal Nanoparticles; Plant Extracts; Prostatic Neoplasms; Receptors, Interleukin-8B; Silver; Uterine Cervical Neoplasms | 2021 |
A SERS-LFA biosensor combined with aptamer recognition for simultaneous detection of thrombin and PDGF-BB in prostate cancer plasma.
Topics: Aged; Antibodies, Monoclonal; Aptamers, Nucleotide; Becaplermin; Biosensing Techniques; Blood Chemical Analysis; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Middle Aged; Oxazines; Prostatic Neoplasms; Sensitivity and Specificity; Silver; Spectrum Analysis, Raman; Thrombin | 2021 |
Insight on cytotoxic effects of silver nanoparticles: Alternative androgenic transactivation by adsorption with DHT.
Topics: Adsorption; Androgens; Biological Availability; Cell Line, Tumor; Dihydrotestosterone; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Silver; Transcriptional Activation | 2018 |
Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
Topics: Antibodies; Antigens, Surface; Biomarkers, Tumor; Early Detection of Cancer; Ferric Compounds; Glutamate Carboxypeptidase II; Humans; Limit of Detection; Magnets; Male; Nanocomposites; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman | 2018 |
Intracellular Biodegradation of Ag Nanoparticles, Storage in Ferritin, and Protection by a Au Shell for Enhanced Photothermal Therapy.
Topics: Animals; Cell Line; Ferritins; Gold; Humans; Hyperthermia, Induced; Male; Metal Nanoparticles; Mice, Nude; PC-3 Cells; Phototherapy; Prostatic Neoplasms; Silver | 2018 |
Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
Topics: Aged; Aged, 80 and over; Algorithms; Antibodies; Antigens, Surface; Benzoates; Biomarkers, Tumor; Glutamate Carboxypeptidase II; Humans; Immunoassay; Limit of Detection; Male; Metal Nanoparticles; Middle Aged; Particle Size; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds; Support Vector Machine; Tissue Kallikreins | 2018 |
"Mix-to-Go" Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Colloids; Colorimetry; Humans; Kallikreins; Male; Metal Nanoparticles; Oncogene Proteins, Fusion; Prostatic Neoplasms; Risk Factors; RNA; Silver; Static Electricity | 2018 |
NF-κB inhibition promotes apoptosis in androgen-independent prostate cancer cells by the photothermal effect via the IκBα/AR signaling pathway.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gold; Hot Temperature; Humans; Indoles; Male; Metal Nanoparticles; Mitochondria; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Oxidative Stress; Phototherapy; Polymers; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Silver; Sulfones | 2019 |
Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Topics: alpha-Fetoproteins; Animals; Antibodies; Biomarkers, Tumor; Biosensing Techniques; Carcinoembryonic Antigen; Collodion; Coloring Agents; Goats; Gold; Humans; Immunoassay; Kallikreins; Limit of Detection; Male; Metal Nanoparticles; Oxazines; Porosity; Prostate-Specific Antigen; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds | 2019 |
Synthesis of silver nanoparticles (AgNPs) from leaf extract of
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Green Chemistry Technology; Humans; Male; Metal Nanoparticles; Plant Extracts; Plant Leaves; Prostatic Neoplasms; Salvia miltiorrhiza; Silver | 2019 |
Tumor-penetrating iRGD peptide inhibits metastasis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell-Penetrating Peptides; Drug Delivery Systems; Humans; Male; Metal Nanoparticles; Mice; Mice, Nude; Neoplasm Metastasis; Neuropilin-1; Oligopeptides; Organ Specificity; Prostatic Neoplasms; Silver; Xenograft Model Antitumor Assays | 2015 |
Silver nanoprism etching-based plasmonic ELISA for the high sensitive detection of prostate-specific antigen.
Topics: Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Equipment Design; Equipment Failure Analysis; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Refractometry; Reproducibility of Results; Sensitivity and Specificity; Silver; Surface Plasmon Resonance | 2015 |
Electrochemiluminescent immunosensing of prostate-specific antigen based on silver nanoparticles-doped Pb (II) metal-organic framework.
Topics: beta-Cyclodextrins; Biosensing Techniques; Electrochemical Techniques; Humans; Lead; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Silver | 2016 |
Development of a spherical (125)i-brachytherapy seed for its application in the treatment of eye and prostate cancer.
Topics: Brachytherapy; Eye Neoplasms; Humans; Iodine Radioisotopes; Male; Microspheres; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Silver; Titanium | 2008 |
Fabrication of Ag@SiO(2)@Y(2)O(3):Er nanostructures for bioimaging: tuning of the upconversion fluorescence with silver nanoparticles.
Topics: Cell Line, Tumor; Europium; Fluorescence; Fluorescent Dyes; Humans; Luminescent Measurements; Male; Materials Testing; Molecular Imaging; Nanostructures; Particle Size; Prostatic Neoplasms; Silicon Dioxide; Silver; Surface Properties; Tissue Distribution; Yttrium | 2010 |
Surface-enhanced Raman scattering detection and tracking of nanoprobes: enhanced uptake and nuclear targeting in single cells.
Topics: Benzoates; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Humans; Male; Metal Nanoparticles; Peptide Fragments; Prostatic Neoplasms; Signal Processing, Computer-Assisted; Silver; Spectrum Analysis, Raman; Sulfhydryl Compounds; tat Gene Products, Human Immunodeficiency Virus | 2010 |
Quantitative ratiometric discrimination between noncancerous and cancerous prostate cells based on neuropilin-1 overexpression.
Topics: Cell Count; Cell Line, Tumor; Humans; In Vitro Techniques; Male; Neuropilin-1; Prostatic Neoplasms; Silver; Spectrum Analysis, Raman | 2011 |
A novel approach for the adsorption of iodine-125 on silver wire as matrix for brachytherapy source for the treatment of eye and prostate cancer.
Topics: Adsorption; Brachytherapy; Eye Neoplasms; Humans; Hydrogen-Ion Concentration; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Silver; Titanium | 2002 |
Myoclonic status epilepticus following repeated oral ingestion of colloidal silver.
Topics: Adenocarcinoma; Administration, Oral; Aged; Argyria; Cerebral Cortex; Colloids; Coma; Complementary Therapies; Epilepsies, Myoclonic; Fatal Outcome; Humans; Male; Persistent Vegetative State; Plasmapheresis; Prostatic Neoplasms; Silver; Status Epilepticus; Treatment Failure | 2004 |
Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy.
Topics: Brachytherapy; Gold Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Photons; Prostatic Neoplasms; Prostheses and Implants; Radiographic Image Enhancement; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Silver; X-Rays | 2004 |
Optical probes for biological applications based on surface-enhanced Raman scattering from indocyanine green on gold nanoparticles.
Topics: Animals; Carcinoma; Gold Colloid; Indocyanine Green; Male; Metal Nanoparticles; Optics and Photonics; Prostatic Neoplasms; Rats; Sensitivity and Specificity; Silver; Spectrum Analysis, Raman; Surface Properties; Tumor Cells, Cultured | 2005 |
High-resolution immunophenotyping of subcellular compartments in tissue microarrays by enzyme metallography.
Topics: Breast Neoplasms; Carcinoma; Cell Compartmentation; Cellular Structures; Colonic Neoplasms; Female; Humans; Immunophenotyping; Kidney Neoplasms; Male; Molecular Probes; Neoplasms; Prostatic Neoplasms; Retrospective Studies; Silver; Tissue Array Analysis | 2005 |
[AGNOR analyses of prostate carcinomas of high and malignancy].
Topics: Cell Nucleolus; Histological Techniques; Humans; Male; Nucleolus Organizer Region; Precancerous Conditions; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Silver | 1993 |
Silver staining nucleolar organizer region in prostate cytology.
Topics: Biopsy; Diagnosis, Differential; Humans; Male; Nucleolus Organizer Region; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis; Silver; Staining and Labeling | 1994 |
Disease progression in stage A prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Humans; Male; Middle Aged; Neoplasm Staging; Nucleolus Organizer Region; Prostatic Neoplasms; Proto-Oncogene Proteins p21(ras); Silver; Staining and Labeling | 1995 |
High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Hormonal; Biopsy, Needle; Carcinoma; Cell Division; Cell Nucleolus; Cell Nucleus; Coloring Agents; Fixatives; Formaldehyde; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Nucleolus Organizer Region; Paraffin Embedding; Prognosis; Prostatic Neoplasms; Risk Factors; Silver; Survival Analysis; Survival Rate; Tissue Fixation | 1997 |
Contrast-enhanced brachytherapy for prostate cancer.
Topics: Animals; Brachytherapy; Contrast Media; Gadolinium; Male; Mice; Monte Carlo Method; Prostatic Neoplasms; Silver | 2002 |
Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates.
Topics: Humans; Male; Nucleolus Organizer Region; Prognosis; Prostatic Hyperplasia; Prostatic Neoplasms; Silver; Staining and Labeling | 1992 |
Semiautomatic quantification of silver-stained nucleolar organizer regions in tissue sections and cellular smears.
Topics: Animals; Cell Cycle; Cell Nucleus; Humans; Image Processing, Computer-Assisted; Leukemia L1210; Male; Nucleolus Organizer Region; Prostatic Neoplasms; Silver; Software; Staining and Labeling; Tumor Cells, Cultured | 1992 |
Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
Topics: Adenocarcinoma; Humans; Hyperplasia; Male; Nucleolus Organizer Region; Prostate; Prostatic Neoplasms; Silver; Staining and Labeling | 1990 |
Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
Topics: Adenocarcinoma; Diagnosis, Differential; Humans; Image Processing, Computer-Assisted; Male; Nucleolus Organizer Region; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Silver | 1990 |
AgNOR staining in benign hyperplasia and carcinoma of the prostate.
Topics: Adenocarcinoma; Humans; Male; Nucleolus Organizer Region; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Silver; Staining and Labeling | 1991 |
Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Histocytochemistry; Male; Nucleolus Organizer Region; Prostate; Prostatic Neoplasms; Rats; Silver; Triptorelin Pamoate | 1991 |
Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
Topics: Cell Nucleus; Histocytochemistry; Humans; Hyperplasia; Male; Microscopy, Electron; Nucleolus Organizer Region; Prostate; Prostatic Diseases; Prostatic Neoplasms; Silver | 1990 |
Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.
Topics: Cell Line; Chromosomal Proteins, Non-Histone; Chromosomes, Human; Humans; Interphase; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Male; Microscopy, Interference; Microscopy, Phase-Contrast; Nucleolus Organizer Region; Prostatic Neoplasms; Silver; Staining and Labeling | 1986 |
Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Fixatives; Histocytochemistry; Hormones; Humans; Immunochemistry; Male; Middle Aged; Peptides; Prostatic Neoplasms; Serotonin; Silver; Staining and Labeling | 1987 |
The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
Topics: Aged; Biomarkers, Tumor; Carcinoma; Cell Differentiation; Chromogranin A; Chromogranins; Humans; Hyperplasia; Immunohistochemistry; Male; Middle Aged; Neurosecretory Systems; Prostate; Prostatic Neoplasms; Silver | 1989 |
Argentaffin and argyrophil cells in the prostate.
Topics: Adenocarcinoma; Chromaffin System; Histocytochemistry; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Silver; Staining and Labeling | 1974 |
Myristoleic acid, a cytotoxic component in the extract from Serenoa repens, induces apoptosis and necrosis in human prostatic LNCaP cells.
Topics: Amino Acid Chloromethyl Ketones; Androgen Antagonists; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Humans; Male; Necrosis; Plant Extracts; Prostatic Neoplasms; Serenoa; Tumor Cells, Cultured | 2001 |